GRI Bio, Inc. (GRI)

GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $3.68 million. The enterprise value is -$4.47 million.

Market Cap	3.68M
Enterprise Value	-4.47M

Important Dates

The last earnings date was Friday, January 30, 2026, before market open.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 1.45 million shares outstanding.

Current Share Class	1.45M
Shares Outstanding	1.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+114.34%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	0.71%
Float	1.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.21
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.01.

Current Ratio	3.25
Quick Ratio	3.11
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -238.17% and return on invested capital (ROIC) is -146.35%.

Return on Equity (ROE)	-238.17%
Return on Assets (ROA)	-103.93%
Return on Invested Capital (ROIC)	-146.35%
Return on Capital Employed (ROCE)	-198.85%
Weighted Average Cost of Capital (WACC)	-2.48%
Revenue Per Employee	n/a
Profits Per Employee	-$2.99M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.89% in the last 52 weeks. The beta is -1.23, so GRI Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.23
52-Week Price Change	-98.89%
50-Day Moving Average	5.49
200-Day Moving Average	35.72
Relative Strength Index (RSI)	27.62
Average Volume (20 Days)	267,239

Short Selling Information

The latest short interest is 156,438, so 10.83% of the outstanding shares have been sold short.

Short Interest	156,438
Short Previous Month	148,008
Short % of Shares Out	10.83%
Short % of Float	10.83%
Short Ratio (days to cover)	0.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.98M
Pretax Income	-11.96M
Net Income	-11.96M
EBITDA	-11.97M
EBIT	-11.98M
Earnings Per Share (EPS)	-$121.80

Balance Sheet

The company has $8.23 million in cash and $71,000 in debt, with a net cash position of $8.16 million or $5.65 per share.

Cash & Cash Equivalents	8.23M
Total Debt	71,000
Net Cash	8.16M
Net Cash Per Share	$5.65
Equity (Book Value)	6.01M
Book Value Per Share	12.07
Working Capital	5.95M

Cash Flow

In the last 12 months, operating cash flow was -$10.19 million and capital expenditures -$3,000, giving a free cash flow of -$10.19 million.

Operating Cash Flow	-10.19M
Capital Expenditures	-3,000
Free Cash Flow	-10.19M
FCF Per Share	-$7.05

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-324.47%
FCF Yield	-276.51%

Analyst Forecast

The average price target for GRI Bio is $644.00, which is 25,154.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$644.00
Price Target Difference	25,154.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 26, 2026. It was a reverse split with a ratio of 1:28.

Last Split Date	Jan 26, 2026
Split Type	Reverse
Split Ratio	1:28

Scores

Altman Z-Score	n/a
Piotroski F-Score	1